MapLight Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -162 | -140 | -136 |
EBITDA | -60,506 | -79,408 | -29,282 |
EBIT | -60,668 | -79,548 | -29,418 |
Net Income | -60,668 | -79,548 | -29,418 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -51,202 | -47,205 | -31,822 |
Cash | 55,707 | 46,729 | 64,146 |
Basic Shares | 45,276 | 44,024 | 41,428 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -578 |
EBITDA | -160,574 |
EBIT | -161,152 |
Net Income | -161,152 |
Net Change In Cash | 0 |
Free Cash Flow | -138,610 |
Cash | 46,729 |
Basic Shares | 44,024 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.34 |
2025-12-31 | -$2.47 |
2025-09-30 | -$37.18 |
2025-06-30 | -$39.11 |